Mounjaro 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3EL0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,553
Award facts
- Contract value 100% obligated
- $15,553.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,553.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro (tirzepatide) 2.5 mg/0.5 mL pen injectors on December 9, 2025, with completion scheduled for December 10, 2025. This non-set-aside contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The delivery location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for federal pharmaceutical procurement.
AmerisourceBergen Drug Corp is a leading pharmaceutical distributor serving critical federal medical supply needs, particularly for military and veteran healthcare systems managed by the Defense Health Agency. The company's extensive portfolio of federal contract awards demonstrates its capability to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This specific delivery order for Mounjaro, a diabetes and weight management medication, reflects the company's ongoing role in supporting the federal government's pharmaceutical supply chain through competitive procurement under the DLA's comprehensive pharmaceutical prime vendor framework.
Quick answers
Who was awarded contract SPE2DR26F3EL0?
SPE2DR26F3EL0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26F3EL0 worth?
The government has obligated $15,553 on SPE2DR26F3EL0.
Is contract SPE2DR26F3EL0 an order under another contract?
Yes. SPE2DR26F3EL0 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3EL0 competed?
The extent of competition for SPE2DR26F3EL0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award